Clave Capital, through the fund Navarra Tech Transfer, consolidates with this new operation its...
User account
Latest News
|
Clave Capital invests in Leadartis in a funding round of more than €1,600,000
14-05-2021
|
Sodena and Capital Cell invest €1.600.000 in the biopharmaceutical Leadartis
30-04-2021
The entry of funds into leadartis' shareholding is part of a round of financing closed by... |
Leadartis announces the publication "An Fc-free EGFR-specific 4-1BB-agonistic trimerbody displays broad anti-tumor activity in humanized murine cancer models without toxicity” in Clinical Cancer Research
02-04-2021
|
